Glaucoma drainage device implantation with adjunctive intravitreal bevacizumab in neovascular glaucoma: 3-year experience
نویسندگان
چکیده
منابع مشابه
Glaucoma drainage device implantation with adjunctive intravitreal bevacizumab in neovascular glaucoma: 3-year experience
PURPOSE To evaluate the outcome of glaucoma drainage device (GDD) implantation with and without intravitreal bevacizumab (IVB) injection in treating neovascular glaucoma (NVG) at Cipto Mangunkusumo Hospital Jakarta, Indonesia. PATIENTS AND METHODS This retrospective study involved 39 eyes with NVG which underwent GDD implantation between 2012 and 2014. Thirty eyes underwent GDD implantation a...
متن کاملIntravitreal bevacizumab and Ahmed glaucoma valve implantation in patients with neovascular glaucoma.
AIM To explore the efficacy of preoperative intravitreal bevacizumab (IVB) injection combined with Ahmed glaucoma valve (AGV) implantation in the treatment of neovascular glaucoma (NVG). METHODS This retrospective study included 35 eyes from 35 patients who underwent preoperative IVB and AGV implantation for treatment of NVG. Findings such as intraocular pressure (IOP) number of anti-glaucoma...
متن کاملIntravitreal bevacizumab (Avastin) injection for neovascular glaucoma.
Neovascular glaucoma is a secondary glaucoma with grave prognosis which follows ischemic retinal disorders in the majority of cases. Mediators that induce new vessel formation such as the vascular endothelial growth factor-A seem to play a key role in the pathophysiology of this condition. Herein, we report 2 cases with neovascular glaucoma secondary to ischemic central retinal vein occlusion w...
متن کاملintravitreal bevacizumab in neovascular glaucoma; a randomized clinical trial
purpose: to determine the effect of intravitreal bevacizumab (ivb) on neovascular glaucoma (nvg) in terms of intraocular pressure (iop), iris neovascularization (nvi) and best-corrected visual acuity (bcva). methods: in this randomized controlled trial, 26 eyes of 26 patients with nvg receiving conventional treatment were randomly allocated to three 2.5 mg ivb injections at 4-week intervals or ...
متن کاملIntravitreal triamcinolone acetonide as adjunctive treatment for neovascular glaucoma.
Neovascular glaucoma is a challenging disease in its pathogenesis and treatment. Ischemic retinopathies can lead to neovascular glaucoma due to newly formed vessels on the iris surface and anterior chamber angle. Eyes with neovascular glaucoma can exhibit high intraocular pressure, usually treated by retinal coagulation, cyclodestructive procedures, or drainage procedures. Based on experimental...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Ophthalmology
سال: 2017
ISSN: 1177-5483
DOI: 10.2147/opth.s137470